Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silverberg JI, Toth D, Bieber T, Alexis AF, et al. Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial. Br J Dermatol 2020 Sep 30. doi: 10.1111/bjd.19573.
PMID: 33000503

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016